What are the systemic associations of Retinitis Pigmentosa (RP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Systemic Associations in Retinitis Pigmentosa

Retinitis pigmentosa (RP) presents with systemic associations in 20-30% of cases, requiring evaluation for ciliopathies, inherited metabolic disorders, mitochondrial disorders, and miscellaneous syndromes to guide prognosis and management. 1

Syndromic RP: Major Categories

Ciliopathies (Most Common Systemic Associations)

Usher Syndrome and Bardet-Biedl Syndrome are the most prevalent ciliopathies associated with RP 1:

  • Usher Syndrome: Progressive sensorineural hearing loss (congenital or early-onset) combined with RP; vestibular dysfunction may be present depending on subtype 1
  • Bardet-Biedl Syndrome: Obesity, polydactyly, renal abnormalities, hypogonadism, cognitive impairment, and RP 1

Less Common Ciliopathies include 1:

  • Cohen syndrome
  • Joubert syndrome (cerebellar vermis hypoplasia, developmental delay, abnormal breathing patterns)
  • Cranioectodermal dysplasia
  • Asphyxiating thoracic dystrophy (Jeune syndrome)
  • Mainzer-Saldino syndrome
  • RHYNS syndrome

Inherited Metabolic Disorders

Peroxisomal Disorders 1:

  • Zellweger spectrum disorders: Craniofacial abnormalities, hepatomegaly, hypotonia, seizures
  • Adult Refsum disease: Peripheral neuropathy, cerebellar ataxia, elevated phytanic acid levels, anosmia
  • α-methylacyl-CoA racemase deficiency: Adult-onset sensory motor neuropathy

Storage and Metabolic Diseases 1:

  • Mucopolysaccharidoses (certain types): Coarse facial features, skeletal abnormalities, organomegaly
  • Neuronal ceroid lipofuscinoses: Progressive cognitive decline, seizures, motor deterioration
  • Abetalipoproteinemia: Fat malabsorption, acanthocytosis, ataxia, low cholesterol
  • Ataxia with vitamin E deficiency: Progressive ataxia, proprioceptive loss

Other Metabolic Associations 1:

  • Mevalonic aciduria: Recurrent fevers, developmental delay, cerebellar ataxia
  • PKAN/HARP syndrome: Dystonia, rigidity, iron accumulation in basal ganglia
  • PHARC syndrome: Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, cataracts
  • Methylmalonic acidaemia with homocystinuria (cblC disease): Developmental delay, megaloblastic anemia

Mitochondrial Disorders

The retina's high metabolic demand makes it vulnerable to mitochondrial dysfunction 1:

  • Kearns-Sayre Syndrome: Progressive external ophthalmoplegia, cardiac conduction defects, onset before age 20, elevated CSF protein 1
  • NARP Syndrome: Neuropathy, ataxia, retinitis pigmentosa; maternal inheritance pattern 1
  • Primary Coenzyme Q10 Deficiency: Variable presentation with encephalomyopathy, ataxia, seizures 1
  • SSBP1-Associated Disease: Optic atrophy, progressive external ophthalmoplegia 1
  • Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: Hypoglycemia, cardiomyopathy, neuropathy 1

Miscellaneous Syndromes

  • Cockayne Syndrome: Premature aging, photosensitivity, cachexia, microcephaly, developmental delay 1
  • PERCHING Syndrome: Does not fit standard classification hierarchy 1

Clinical Implications and Management Approach

Diagnostic Evaluation

When RP is diagnosed, systematically assess for 1:

  • Hearing loss (audiometry for Usher syndrome)
  • Obesity, polydactyly, renal function (Bardet-Biedl syndrome)
  • Ataxia, peripheral neuropathy (Refsum disease, mitochondrial disorders)
  • Developmental delay, cognitive impairment (multiple syndromes)
  • Cardiac conduction abnormalities (Kearns-Sayre syndrome)
  • Metabolic screening: Phytanic acid, very long chain fatty acids, plasma amino acids, acylcarnitine profile

Impact on Prognosis and Treatment

Accurate syndromic diagnosis is essential because 2, 1:

  • Systemic manifestations may be life-threatening (cardiac conduction defects in Kearns-Sayre, renal disease in Bardet-Biedl)
  • Some conditions have specific dietary interventions (phytanic acid restriction in Refsum disease)
  • Genetic counseling differs based on inheritance pattern (autosomal recessive vs. mitochondrial)
  • Several first-in-human clinical trials are underway for specific syndromic forms of RP 1

Quality of Life Considerations

RP causes greater emotional and psychological impact than diabetic retinopathy or age-related macular degeneration, with progressive vision loss severely affecting daily tasks, employment, and independence 2. The addition of systemic manifestations in syndromic RP compounds this burden significantly 2, 1.

Common Pitfalls

  • Failing to screen for hearing loss: Usher syndrome may present with RP before hearing loss is recognized as progressive 1
  • Missing cardiac screening in Kearns-Sayre syndrome: Cardiac conduction defects can be fatal if undetected 1
  • Overlooking metabolic screening: Treatable conditions like Refsum disease require specific dietary modifications 1
  • Assuming isolated RP: 20-30% of RP cases are syndromic, requiring systematic evaluation even when no obvious systemic features are initially apparent 1

References

Research

Syndromic retinitis pigmentosa.

Progress in retinal and eye research, 2025

Research

Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs.

Clinical ophthalmology (Auckland, N.Z.), 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.